Full Text View
Tabular View
No Study Results Posted
Related Studies
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
This study is ongoing, but not recruiting participants.
First Received: September 13, 2005   Last Updated: March 13, 2009   History of Changes
Sponsor: Temple University
Collaborator: University of Pennsylvania
Information provided by: Temple University
ClinicalTrials.gov Identifier: NCT00194259
  Purpose

This study will assess the effects of weight loss on sleep-disordered breathing (SDB) in 120 obese, type 2 diabetics with obstructive sleep apnea (OSA) from four Look AHEAD sites. Changes in SDB will be compared between subjects randomized to weight loss (Lifestyle Intervention Group) versus non-weight loss (Diabetes Education and Support Group) conditions within the context of the Look AHEAD Study. Weight loss is frequently recommended for obese patients with OSA, but the empirical foundation for this recommendation is not well substantiated. Weight loss in obese apneics improves but does not eliminate SDB. Moreover, the degree of improvement is not correlated with the amount of weight loss. This study will assess SDB before treatment and at 1 and 2 years. We will also investigate clinical measures of fat distribution that may mediate the non-linear relationship between weight loss and improvements in SDB. Finally, we will examine the role of SDB in mediating changes in blood pressure associated with weight loss.


Condition
Obstructive Sleep Apnea
Type 2 Diabetes

Study Type: Observational
Study Design: Cohort, Prospective
Official Title: Sleep Apnea in Look AHEAD (Action for Health in Diabetes)

Resource links provided by NLM:


Further study details as provided by Temple University:

Biospecimen Retention:   Samples Without DNA

Biospecimen Description:

Saliva Samples


Enrollment: 320
Study Start Date: August 2001
Estimated Study Completion Date: August 2009
Estimated Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   45 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with Type II diabetes previously enrolled into the "Look-AHEAD" Study. Comid diagnosis of sleep apnea

Criteria

Inclusion Criteria:

  • Enrollment in LookAhead
  • Type II Diabetes and Sleep Apnea

Exclusion Criteria:

  • Determined by parent study, LookAhead
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00194259

Locations
United States, New York
St. Luke's Roosevelt Hospital
New York, New York, United States, 10025
United States, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15213
United States, Rhode Island
Brown University
Providence, Rhode Island, United States, 02903
Sponsors and Collaborators
Temple University
University of Pennsylvania
Investigators
Principal Investigator: Gary D Foster, Ph.D. Temple University
Principal Investigator: Richard Millman, M.D. Brown University
Principal Investigator: Mark Sanders, AB, MD, FCCP, D'ABSM University of Pittsburgh
Principal Investigator: Gary Zammit, Ph.D. St. Luke's-Roosevelt Hospital Center
Principal Investigator: Samuel T Kuna, M.D. University of Pennsylvania
  More Information

No publications provided by Temple University

Additional publications automatically indexed to this study by National Clinical Trials Identifier (NCT ID):
Responsible Party: Temple University ( Gary Foster, PhD )
Study ID Numbers: HL70301
Study First Received: September 13, 2005
Last Updated: March 13, 2009
ClinicalTrials.gov Identifier: NCT00194259     History of Changes
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Sleep Apnea Syndromes
Metabolic Diseases
Apnea
Nervous System Diseases
Sleep Apnea, Obstructive
Respiration Disorders
Diabetes Mellitus
Sleep Disorders
Dyssomnias
Endocrine System Diseases
Sleep Disorders, Intrinsic
Signs and Symptoms
Respiratory Tract Diseases
Diabetes Mellitus, Type 2
Signs and Symptoms, Respiratory
Glucose Metabolism Disorders

ClinicalTrials.gov processed this record on February 08, 2010